Is the Anti-Hypertensive Effect of Dietary Supplements via Aldehydes Reduction Evidence Based? A Systematic Review

References

• Romero JC, Reckelhoff JF. State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999; 34: 943–949
   PubMed Web of Science ®Google Scholar
• Redon J, Oliva MR, Tormos C, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003; 41: 1096–1101
   PubMed Web of Science ®Google Scholar
• Ward NC, Croft KD. Hypertension and oxidative stress. Clin Exp Pharmacol Physiol. 2006; 33: 872–876
   PubMed Web of Science ®Google Scholar
• Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension?. Free Radic Res Commun. 1993; 19: 59–66
   PubMed Web of Science ®Google Scholar
• Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: Role of heredity, gender, and ethnicity. Hypertension. 2000; 36: 878–884
   PubMed Web of Science ®Google Scholar
• Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens. 2000; 14: 343–345
   PubMed Web of Science ®Google Scholar
• Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res. 2006; 71: 247–258
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CN, Longerich L, Parai S. A nutritional approach to prevent high blood pressure. Atherosclerosis, hypertension and diabetes, GN Pierce, M Nagano, P Zahradka, NS Dhalla. Kluwer Academic Publishers, Norwell, Mass 2003; 187–196
   Google Scholar
• Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADH-dependent aldo-keto reductases: Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem. 1992; 267: 4364–4369
   PubMed Web of Science ®Google Scholar
• Phillips SA, Mirrlees D, Thornalley PJ. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor statil. Biochem Pharmacol. 1993; 46: 805–811
   PubMed Web of Science ®Google Scholar
• Leoncini G, Maresca M, Buzzi E. Inhibition of the glycolytic pathway by methylgloxal in human platelets. Cell Biochem Funct. 1989; 7: 65–70
   PubMed Web of Science ®Google Scholar
• Brandt RB, Siegel SA. Methylglyoxal production in human blood. Submolecular biology and cancer. Excerpta Medica, CIBA Foundation Symposium. 1979; 67: 211–223
   Google Scholar
• Vasdev S, Gill V, Singal P. Role of advanced glycation end products in hypertension and atherosclerosis: Therapeutic implications. Cell Biochem Biophys. 2007; 49: 48–63
   PubMed Web of Science ®Google Scholar
• Chang T, Wu L. Methylglyoxal, oxidative stress, and hypertension. Can J Physiol Pharmacol. 2006; 84: 1229–1238
   PubMed Web of Science ®Google Scholar
• Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med. 2000; 28: 1685–1696
   PubMed Web of Science ®Google Scholar
• Murphy BJ, Washkurak AW, Tuana BS. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: Role of disulfide, sulfhydryl and phosphate groups. Biochim Biophys Acta. 1990; 1052: 333–339
   PubMed Web of Science ®Google Scholar
• Zaidi NF, Lagenaur CF, Abramson JJ, Pessah I, Salama G. Reactive disulfides trigger Ca2+ release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem. 1989; 264: 21725–21736
   PubMed Web of Science ®Google Scholar
• Vasdev S, Barrett B, Longerich L, Ford CA. Ethanol-induced hypertension: The role of acetaldehyde. Pathophysiology of heart failure, NS Dhalla. Kluwer Academic Publishers, Norwell, Mass 1996; 77–93
   Google Scholar
• Vasdev S, Longerich L, Ford CA. Role of aldehydes in hypertension. Adaptation biology and medicine, BK Sharma, N Takeda, NK Ganguly, PK Singal. Narosa Publishing House, New DelhiIndia 1997; 1: 326–339
   Google Scholar
• Brandwein HJ, Lewicki JA, Murad F. Reversible inactivation of guanylate cyclase by mixed disulfide formation. J Biol Chem. 1981; 256: 2958–2962
   PubMed Web of Science ®Google Scholar
• Degenhardt TP, Thorpe SR, Baynes JW. Chemical modification of proteins by methylglyoxal. Cell Mol Biol. 1998; 44: 1139–1145
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S. Aldehyde induced hypertension in rats: Prevention by N-acetyl cysteine. Artery. 1998; 23: 10–36
   PubMedGoogle Scholar
• Vasdev S, Mian T, Ford CA, Longerich L, Parai S. Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertensive rats. Nutr Metab Cardiovasc Dis. 1996; 6: 130–140
   Web of Science ®Google Scholar
• Wu L, Juurlink BHJ. Increased methylglyoxal and oxidative stress in hypertensive vascular smooth muscle cells. Hypertension. 2002; 39: 809–814
   PubMed Web of Science ®Google Scholar
• Thornalley PJ. Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem Soc Trans. 1993; 21: 531–534
   PubMed Web of Science ®Google Scholar
• Meister A, Anderson ME, Hwang O. Intracellular cysteine, and glutathione delivery systems. J Am Coll Nutr. 1986; 5: 137–151
   PubMed Web of Science ®Google Scholar
• Ferrari R, Ceconi C, Curello S. Oxygen free radicals and myocardial damage: Protective role of thiol-containing agents. Am J Med. 1991; 91(Suppl. 3C)95–105
   Google Scholar
• Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S. Role of aldehydes in fructose induced hypertension. Mol Cell Biochem. 1998; 181: 1–9
   PubMed Web of Science ®Google Scholar
• Meister A. Commentary on the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol. 1992; 44: 1905–1915
   PubMed Web of Science ®Google Scholar
• Paolisso G, Balbi V, Volpe C, Varricchio G, Gambardella A, Saccomanno F, Ammendola S, Varricchio M, D' Onofrio F. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr. 1995; 14: 387–392
   PubMed Web of Science ®Google Scholar
• Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994; 269: 9397–9400
   PubMed Web of Science ®Google Scholar
• Johnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr. 1993; 58: 103–105
   PubMed Web of Science ®Google Scholar
• Janero DR, Burghadt B. Cardiac membrane vitamin E and malondialdehyde levels in heart muscle of normotensive and spontaneously-hypertensive rats. Lipids. 1989; 24: 33–38
   PubMed Web of Science ®Google Scholar
• Uysal M, Bulur H, Sener D, Oz H. Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol. 1986; 24: 474–476
   PubMedGoogle Scholar
• Paolisso G, D'Amore A, Balbi V, Galzerano D, Guigliano D, Sgambato S, Varricchio M, D' Onofrio F. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetes. Am J Physiol. 1994; 266: E261–E268
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem. 2001; 218: 97–103
   PubMed Web of Science ®Google Scholar
• Yoshioka M, Aoyama K, Matsushita T. Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). Int J Vitam Nutr Res 1985; 55: 301–307
   PubMed Web of Science ®Google Scholar
• Ziemlanski S, Wartanowicz M, Potrzebnicka K, Burgos de Moor A, Iwanow K, Ignatowska-Switalska M, Selakiewicz K. Effect of exogenous ascorbic acid on experimental hypertension and mineral balance in rats fed low- and high-fat diets. Nutrition. 1991; 7: 131–135
   PubMed Web of Science ®Google Scholar
• Akpaffiong MJ, Taylor AA. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens. 1998; 11: 1450–1460
   PubMed Web of Science ®Google Scholar
• Vasdev S, Longerich L, Singal P. Nutrition and hypertension. Nutr Res. 2002; 22: 111–123
   Web of Science ®Google Scholar
• Vasdev S, Gill V, Parai S, Longerich L, Gadag V. Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats. Mol Cell Biochem. 2002; 241: 107–114
   PubMed Web of Science ®Google Scholar
• Ettarh RR, Odigie IP, Adigun SA. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Physiol Pharmacol. 2002; 80(12)1199–1202
   PubMed Web of Science ®Google Scholar
• Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, Feldman DS. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr. 1993; 57: 213–217
   PubMed Web of Science ®Google Scholar
• Ness AR, Chee D, Elliott P. Vitamin C and blood pressure—an overview. J Hum Hypertens. 1997; 11: 343–350
   PubMed Web of Science ®Google Scholar
• Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 2001; 37: 261–267
   PubMed Web of Science ®Google Scholar
• Duffy SJ, Gokce N, Holbrook M. Treatment of hypertension with ascorbic acid. Lancet. 1999; 354: 2048–2049
   PubMed Web of Science ®Google Scholar
• Hajjar IM, George V, Sasse EA, Kochar MS. A randomized, doubleblind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther. 2002; ;9: 289–293
   PubMedGoogle Scholar
• Mullan BA, Young IS, Fee H, McCance DR. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension. 2002; 40: 804–809
   PubMed Web of Science ®Google Scholar
• Trout DL. Vitamin C and cardiovascular risk factors. Am J Clin Nutr. 1991; 53: 322S–325S
   PubMed Web of Science ®Google Scholar
• Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland. BMJ 1997; 314: 634–638
   PubMed Web of Science ®Google Scholar
• Kurl S, Tuomainen TP, Laukkanen JA, Nyyssonen K, Lakka T, Sinevius J, Salonen JT. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke. 2002; 33: 1568–1573
   PubMed Web of Science ®Google Scholar
• Kim MK, Sasaki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension. 2002; 40: 797–803
   PubMed Web of Science ®Google Scholar
• Ghosh SK, Ekpo EB, Shah IU, Girling AJ, Jenkins C, Sinclair AJ. A double-blind, placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology. 1994; 40: 268–272
   PubMed Web of Science ®Google Scholar
• Magen E, Viskoper R, Mishal J, Priluk R, Berezovsky A, Laszt A, London D, Yosefy C. Resistant arterial hypertension and hyperlipidemia: Atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J. 2004; 6: 742–746
   PubMed Web of Science ®Google Scholar
• Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin Sci (Lond). 2002; 103: 339–344
   PubMed Web of Science ®Google Scholar
• Stamler J, Liu K, Ruth KJ, Pryer J, Greenland P. Eight-year blood pressure change in middle-aged men: Relationship to multiple nutrients. Hypertension. 2002; 39: 1000–1006
   PubMed Web of Science ®Google Scholar
• Whelton P, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of oral potassium on blood pressure: Meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624–1632
   PubMed Web of Science ®Google Scholar
• Block G, Mangel AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension. 2001; 37: 261–267
   PubMed Web of Science ®Google Scholar
• Svetkey PL, Loria MC. Blood pressure effects of vitamin C: What's the key question?. Hypertension. 2002; 40: 789–791
   PubMed Web of Science ®Google Scholar
• Loria CM. Vitamin C status and cardiovascular disease: A review of prospective studies. The antioxidant vitamins C and E, B Frei, M. Traber. AOCS Press, Champaign, Ill 2002; 298
   Google Scholar
• Lehninger AL. Biochemistry: The molecular basis of cell structure and function 2nd. Worth Publishers, Inc, New York 1978; 698
   Google Scholar
• Smolin LA, Benevenga NJ. Accumulation of homocyst(e)ine in vitamin B-6 deficiency: A model for the study of cystathionine β synthase deficiency. J Nutr. 1982; 112: 1264–1272
   PubMed Web of Science ®Google Scholar
• Finkelstein JD, Chalmers FT. Pyridoxine effects on cystathionine synthase in rat liver. J Nutr. 1970; 100: 467–469
   PubMed Web of Science ®Google Scholar
• Takeuchi F, Izuta S, Tsubouchi R, Shibata Y. Glutathione levels and related enzyme activities in vitamin B-6 deficient rats fed a high methioinine and low cystine diet. J Nutr. 1991; 121: 1366–1373
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin B6 supplementation attenuates hypertension in spontaneously hypertensive rats. Mol Cell Biochem. 1999; ;200: 155–162
   PubMed Web of Science ®Google Scholar
• Lal KJ, Dakshinamurti K, Thliveris J. The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J Hypertens., 14: 1996, 355–363
   Web of Science ®Google Scholar
• Bennink HJTC, Schreurs WHP. Improvement of oral glucose tolerance in gestational diabetes by pyridoxine. Br Med J. 1975; 3: 13–15
   PubMed Web of Science ®Google Scholar
• Spellacy WN, Buhi WC, Birk SA. Vitamin B6 treatment of gestational diabetes mellitus. Am J Obstet Gynecol. 1977; 127: 599–602
   PubMed Web of Science ®Google Scholar
• Aybak M, Sermet A, Ayyildiz MO, Karakilcik AZ. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzeimittel-Forschung. 1995; 45: 1271–1273
   PubMed Web of Science ®Google Scholar
• McCarty MF. High-dose pyridoxine as an anti-stress strategy. Medical Hypotheses. 2000; 54: 803–807
   PubMed Web of Science ®Google Scholar
• Walker BR. Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease. Endocrinol Res. 1996; 22: 701–708
   PubMed Web of Science ®Google Scholar
• Chasan-Taber L, Selhub J, Rosenberg IH, Malinow MR, Terry P, Tishler PV, Willett W, Hennekens CH, Stampfer MJ. A prospective study of folate and vitamin B6 and risk of myocardial infarction in U.S. physicians. J Am Coll Nutr. 1996; 15(2)136–143
   PubMed Web of Science ®Google Scholar
• Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 1998; 279(5)359–364
   PubMed Web of Science ®Google Scholar
• Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens. 2003; 16: 173–179
   PubMed Web of Science ®Google Scholar
• Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med. 1995; 19: 227–250
   PubMed Web of Science ®Google Scholar
• Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. BioFactors. 1997; 6: 321–338
   PubMed Web of Science ®Google Scholar
• Busse E, Zimmer G, Schopohl B, Kornhuber B. Influence of a-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittel-Forschung. 1992; 42: 829–831
   PubMed Web of Science ®Google Scholar
• Packer L, Roy S, Sen CK. a-Lipoic acid: A metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol. 1999; 38: 79–101
   Google Scholar
• Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittel-Forschung. 1995; 45: 872–874
   PubMed Web of Science ®Google Scholar
• Konrad T, Vicini P, Kusterer A, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. a-Lipoic acid treatment decreases serum lactate and pyruvate concentrations, and improves glucose effectiveness in lean, and obese patients with type 2 diabetes. Diabetes Care. 1999; 22: 280–287
   PubMed Web of Science ®Google Scholar
• Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ, Henriksen EJ. The antioxidant a-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 1996; 45: 1024–1029
   PubMed Web of Science ®Google Scholar
• Kocak G, Aktan F, Canbolat O, Ozogul C, Elbeg S, Yildizoglu-Ari N, Karasu C. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes. Diabetes Nutr Metab. 2000; 13: 308–318
   PubMedGoogle Scholar
• Coombes JS, Powers SK, Hamilton KL. Improved cardiac performance after ischemia in aged rats supplemented with vitamin E and alipoic acid. Am J Physiol. 2000; 279: R2149–R2155
   Web of Science ®Google Scholar
• Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y. Effects of a-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur J Pharmacol. 2001; 424: 121–129
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary a-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens. 2000; 18: 567–573
   PubMed Web of Science ®Google Scholar
• Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metab Cardiovasc Dis. 2000; 10: 339–346
   PubMed Web of Science ®Google Scholar
• Midaoui AE, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by a-lipoic acid. Hypertension. 2002; 39: 303–307
   PubMed Web of Science ®Google Scholar
• Louhelainen M, Merasto S, Finckenberg P, Lapatto R, Cheng JZ, Mervaala EMA. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J Hypertens. 2006; 24: 947–956
   PubMed Web of Science ®Google Scholar
• Vasdev S, Gill V, Parai S, Gadag V. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem. 2005; 275: 135–141
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats. J Comp Physiol. 2004; 174: 587–592
   Web of Science ®Google Scholar
• Morcos M, Borcea V, Isemann B, Gehrke S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler H, Ziegler R, Wahl P, Nawroth PP. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: An exploratory study. Diab Res Clin Prac. 2001; 52: 175–183
   PubMed Web of Science ®Google Scholar
• Conlin PR, Chow D, Miller ER I, II, Svetkey LP, Lin PH, Harsha DW, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ. The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens. 2000; 13: 949–955
   PubMed Web of Science ®Google Scholar
• John JH, Ziebland S, Yudkin P, Roe LS, Neil HA. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: A randomised controlled trial. Lancet. 2002; 359: 1969–1974
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206–1252
   PubMed Web of Science ®Google Scholar
• Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER I, II, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced dietary sodium an the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001; 344: 3–10
   PubMed Web of Science ®Google Scholar
• Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. N Eng J Med. 1997; 336: 117–124
   Web of Science ®Google Scholar
• Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N. Effects of diet and sodium intake on blood pressure: A subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001; 135: 1019–1028
   PubMed Web of Science ®Google Scholar
• Jialal I, Devaraj S. Antioxidants and atherosclerosis: Don't throw out the baby with the bath water. Circulation. 2003; 107: 926–928
   PubMed Web of Science ®Google Scholar
• Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med. 1995; 123: 860–872
   PubMed Web of Science ®Google Scholar
• Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr. 1996; 64: 190–196
   PubMed Web of Science ®Google Scholar
• Newaz MA, Nawal NNA. Effect of α-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens. 1998; 11: 1480–1485
   PubMed Web of Science ®Google Scholar
• Vasdev S, Gill V, Parai S, Longerich L, Gadag V. Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem. 2002; 238: 111–117
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC, HOPE Study, MICRO-HOPE Study. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: Results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002; 25: 1919–1927
   PubMed Web of Science ®Google Scholar
• Czermichow S, Bertrais S, Blacher J, Galan P, Briancon S, Favier A, Safar M, Hercberg S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study. Association with antioxidant levels. J Hypertens. 2005; 23: 2013–2018
   PubMed Web of Science ®Google Scholar
• McInnes TG. Antioxidants and hypertension: Another false dawn?. J Hypertens. 2005; 23: 1963–1966
   PubMed Web of Science ®Google Scholar
• Wexler R, Aukerman G. Nonpharmacologic strategies for managing hypertension. Am Fam Physician. 2006; 73: 1953–1956
   PubMed Web of Science ®Google Scholar